Advertisement

Updated Technology and Early Detection of Cancers: Pulmonary, Breast, Colon, and Prostate

  • Fabrice DenisEmail author
Chapter
Part of the Practical Issues in Geriatrics book series (PIG)

Abstract

Early detection of cancer or cancer relapse is an important issue to improve survival. However, up to now, one of the most common strategies to early detect cancer or for a routine follow-up after cancer treatment is to track the appearance of tumors by performing regular clinical assessments with (or without) imaging at a few months or years of interval. Nevertheless, such a follow-up is not always without any risk since, for instance, patients with non-Hodgkin’s lymphoma who received more than 8 CT scans have a probability for secondary primary malignancies twice greater than those who received less than 8.

Keywords

Web-mediated follow-up Cancer Early detection e-health 

References

  1. 1.
    Kahl BS, Armitage JO, Redberg R. CT use in NHL patients increase cancer risk, 19th Congress of the European Hematology 67 Association (EHA): 2014 Abstract BSSUB-3488Google Scholar
  2. 2.
    Masters GA, Temin S, Azzoli CG et al (2015) Systemic therapy for stage IV non-small-cell lung Cancer: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol 33:3488–3515CrossRefGoogle Scholar
  3. 3.
    Meregaglia M, Cairns J (2015) Economic evaluations of follow-up strategies for cancer survivors: a systematic review and quality appraisal of the literature. Expert Rev Pharmacoecon Outcomes 15(6):913–929CrossRefGoogle Scholar
  4. 4.
    Walsh GL, O’Connor M, Willis KM et al (1995) Is follow-up of lung cancer patients after resection medically indicated and cost-effective? Ann Thorac Surg 60:1563–1570CrossRefGoogle Scholar
  5. 5.
    Westeel V, Choma D, Clement F et al (2000) Relevance of an intensive postoperative follow-up after surgery for non-small cell lung cancer. Ann Thorac Surg 70:1185–1190CrossRefGoogle Scholar
  6. 6.
    Selby JV, Beal AC, Frank L (2012) The Patient-Centered Outcomes Research Institute (PCORI) national priorities for research and initial research agenda. JAMA 307:1583–1584CrossRefGoogle Scholar
  7. 7.
    Basch E, Artz D, Dulko D et al (2005) Patient online self-reporting of toxicity symptoms during chemotherapy. J Clin Oncol 23:3552–3561CrossRefGoogle Scholar
  8. 8.
    Denis F, Viger L, Charron A et al (2014) Detecting lung cancer relapse using self-evaluation forms weekly filled at home: the sentinel follow-up. Support Care Cancer 22:79–85CrossRefGoogle Scholar
  9. 9.
    Denis F, Viger L, Charron A et al (2014) Detection of lung cancer relapse using self-reported symptoms transmitted via an internet web-application: pilot study of the sentinel follow-up. Support Care Cancer 22:1467–1473CrossRefGoogle Scholar
  10. 10.
    Denis F, Yossi S, Septans AL et al (2017) Improving survival in patient treated for a lung cancer using self-evaluated symptoms reported via a web-application. Am J Clin Oncol 40(5):464–469CrossRefGoogle Scholar
  11. 11.
    Denis F, Lethrosne C, Pourel N et al (2017) Randomized trial comparing a web-mediated follow-up to routine surveillance in lung cancer patients. J Natl Cancer Inst 109(9).  https://doi.org/10.1093/jnci/djx029
  12. 12.
    Bakitas MA, Tosteson TD, Li Z et al (2015) Early versus delayed initiation of concurrent palliative oncology care: patient outcomes in the ENABLE III randomized controlled trial. J Clin Oncol 33:1438–1445CrossRefGoogle Scholar
  13. 13.
    Basch E, Deal AM, Kris MG et al (2015) Symptom monitoring with patient-reported outcomes during routine cancer treatment: a randomized controlled trial. J Clin Oncol 34:557–565CrossRefGoogle Scholar
  14. 14.
    Basch E (2017) Patient-reported outcomes—harnessing patients’ voices to improve clinical care. NEJM 376:105–108CrossRefGoogle Scholar
  15. 15.
    Ironmonger L, Ohuma E, Ormiston-Smith N et al (2015) An evaluation of the impact of large-scale interventions to raise public awareness of a lung cancer symptom. Br J Cancer 112:207–216CrossRefGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2019

Authors and Affiliations

  1. 1.Institut Inter-régional de Cancérologie Jean BernardLe MansFrance

Personalised recommendations